185 related articles for article (PubMed ID: 8535203)
21. Leukemias with megakaryoblastic involvement: clinical, hematologic, and immunologic characteristics.
San Miguel JF; Gonzalez M; Cañizo MC; Ojeda E; Orfao A; Caballero MD; Moro MJ; Fisac P; Lopez Borrasca A
Blood; 1988 Aug; 72(2):402-7. PubMed ID: 3165292
[TBL] [Abstract][Full Text] [Related]
22. Blast cell deficiency of CD11a as a marker of acute megakaryoblastic leukemia and transient myeloproliferative disease in children with and without Down syndrome.
Boztug H; Schumich A; Pötschger U; Mühlegger N; Kolenova A; Reinhardt K; Dworzak M
Cytometry B Clin Cytom; 2013; 84(6):370-8. PubMed ID: 23450818
[TBL] [Abstract][Full Text] [Related]
23. Relapse of acute myelogenous leukemia as a cerebellar myeloblastoma showing megakaryoblastic differentiation.
Lorsbach RB; Folkerth RD; Pinkus GS
Mod Pathol; 1999 Dec; 12(12):1186-91. PubMed ID: 10619274
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric analysis of peroxidase negative acute leukemias by monoclonal antibodies--II. Acute megakaryoblastic and acute pro-megakaryocytic leukemias.
Imamura N; Kajihara H; Kuramoto A
Leuk Res; 1988; 12(4):279-89. PubMed ID: 3163741
[TBL] [Abstract][Full Text] [Related]
25. Acute megakaryoblastic leukemia in Down syndrome.
Hitzler JK
Pediatr Blood Cancer; 2007 Dec; 49(7 Suppl):1066-9. PubMed ID: 17943965
[TBL] [Abstract][Full Text] [Related]
26. [Phenotypic analysis of acute megakaryoblastic leukemia following myelodysplastic syndrome. Evidence for leukemic cells reacting with 3A1 (CD7) and A2B5 monoclonal antibodies].
Uike N; Kozuru M; Takeichi N; Shibata K; Akiyoshi T; Anami K; Shibuya T; Niho Y; Oku K; Takeshita M
Rinsho Ketsueki; 1988 Jun; 29(6):889-95. PubMed ID: 3166500
[No Abstract] [Full Text] [Related]
27. Differentiation induction of blast cells in two cases of childhood acute megakaryoblastic leukemia in vitro by interleukin-3 and interleukin-6: an ultrastructural cytochemical study.
Miyauchi J; Sugita K; Okui M; Taguchi N; Clark SC; Shimizu K
J Cell Physiol; 1991 Sep; 148(3):404-13. PubMed ID: 1655816
[TBL] [Abstract][Full Text] [Related]
28. [Analytical study on leukemic megakaryocytic cells using simultaneous demonstration of membrane antigen with monoclonal antibodies and peroxidase cytochemistry at ultrastructural level].
Enomoto Y; Watanabe Y
Rinsho Ketsueki; 1988 Aug; 29(8):1150-62. PubMed ID: 2849691
[No Abstract] [Full Text] [Related]
29. Target cell of leukemic transformation in acute megakaryoblastic leukemia.
Koike T; Urushiyama M; Narita M; Saitoh H; Ishida F; Imashuku S; Morioka Y; Utsumi J; Ishizuka T; Tsuruta T
Am J Hematol; 1990 Aug; 34(4):252-8. PubMed ID: 2164321
[TBL] [Abstract][Full Text] [Related]
30. [Surface antigens of megakaryocytes].
Koike T; Furukawa T
Rinsho Byori; 1991 Sep; Suppl 91():205-16. PubMed ID: 1758071
[No Abstract] [Full Text] [Related]
31. Myelodysplastic syndromes (MDS) and acute myeloid leukemias (AML) with myelofibrosis.
Imbert M; Nguyen D; Sultan C
Leuk Res; 1992; 16(1):51-4. PubMed ID: 1732672
[TBL] [Abstract][Full Text] [Related]
32. Limits of phenotypic markers for the diagnosis of megakaryoblastic leukemia.
Breton-Gorius J; Villeval JL; Kieffer N; Mitjavila MT; Guichard J; Vainchenker W
Blood Cells; 1989; 15(1):259-77. PubMed ID: 2649184
[TBL] [Abstract][Full Text] [Related]
33. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
[No Abstract] [Full Text] [Related]
34. Down syndrome with myelodysplasia of megakaryoblastic lineage.
Henderson R; Spence L
Clin Lab Sci; 2006; 19(3):161-4. PubMed ID: 16910232
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of a cell line established from a case of acute megakaryoblastic leukemia.
Skinnider LF; Pabello P; Zheng CY
Acta Haematol; 1997; 98(1):26-31. PubMed ID: 9210910
[TBL] [Abstract][Full Text] [Related]
36. Simultaneous detection of platelet-associated antigen and platelet peroxidase on buffy coat cells from bone marrow in two patients with pediatric acute megakaryocytic leukemia.
Kinugawa N; Okimoto Y; Hata J
J Pediatr Hematol Oncol; 1999; 21(5):451-2. PubMed ID: 10524465
[No Abstract] [Full Text] [Related]
37. Acute megakaryoblastic leukemia in Down syndrome, following thrombocytopenia with antiplatelet antibody.
Sumi S; Obayashi M; Murakami M; Ito J; Okada N; Shibata Y
Tohoku J Exp Med; 1990 May; 161(1):65-7. PubMed ID: 2144373
[TBL] [Abstract][Full Text] [Related]
38. Leukemic blasts with markers of four cell lineages in Down's syndrome ("megakaryoblastic leukemia").
Slørdahl SH; Smeland EB; Holte H; Grønn M; Lie SO; Seip M
Med Pediatr Oncol; 1993; 21(4):254-8. PubMed ID: 8469219
[TBL] [Abstract][Full Text] [Related]
39. Transient abnormal myelopoiesis followed by acute megakaryoblastic leukemia with extramedullary tumors. An autopsied case of Down's syndrome.
Nito T; Terashima K; Matsuda M; Imai Y; Yokoyama S; Hayashi T
Acta Pathol Jpn; 1983 Sep; 33(5):1027-39. PubMed ID: 6228108
[TBL] [Abstract][Full Text] [Related]
40. The proto-oncogene ERG in megakaryoblastic leukemias.
Rainis L; Toki T; Pimanda JE; Rosenthal E; Machol K; Strehl S; Göttgens B; Ito E; Izraeli S
Cancer Res; 2005 Sep; 65(17):7596-602. PubMed ID: 16140924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
